中国医药导报
中国医药期刊欢迎您 今天是   2025年4月6日星期天
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  临床医学-神经系统疾病 本期目录 | 过刊浏览 | 高级检索 |
血清miR-125a-3p、miR-224-3p表达与脑梗死患者颈动脉粥样硬化斑块的关系
李星  刘京锋  李博
北京市和平里医院神经内科,北京   100013
Relationship between the expression of miR-125a-3p and miR-224-3p in serum and carotid atherosclerotic plaque in patients with cerebral infar-ction
LI Xing   LIU Jingfeng   LI Bo
Department of Neurology, Beijing Hepingli Hospital, Beijing   100013, China
全文: PDF (636 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨血清miR-125a-3p、miR-224-3p表达与脑梗死颈动脉粥样硬化(CAS)斑块的关系。 方法 选取2019年3月至2021年12月北京市和平里医院收治的120例脑梗死患者,根据CAS斑块稳定性将其分为不稳定组(75例)和稳定组(45例)。收集并比较两组临床资料,同时采用实时荧光定量PCR检测两组血清miR- 125a-3p、miR-224-3p表达。通过logistic回归模型分析脑梗死患者CAS不稳定的影响因素,进一步采用受试者操作特征(ROC)曲线分析其对脑梗死患者CAS斑块稳定情况的预测价值。 结果 不稳定组吸烟者占比、糖尿病患者占比、低密度脂蛋白胆固醇(LDL-C)、miR-125a-3p表达高于稳定组,miR-224-3p表达低于稳定组,差异有统计学意义(P<0.05)。多因素分析显示,吸烟、糖尿病、LDL-C、miR-125a-3p、miR-224-3p均为脑梗死患者CAS斑块不稳定的影响因素(P<0.05),5项联合预测脑梗死患者CAS斑块不稳定的ROC曲线下面积为0.915,灵敏度、特异度分别为84.00%、91.11%。 结论 脑梗死患者血清miR-125a-3p、miR-224-3p水平与CAS斑块不稳定有关,可联合吸烟、糖尿病和LDL-C对CAS斑块不稳定进行预测。

服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
李星  刘京锋  李博
关键词 脑梗死miR-125a-3pmiR-224-3p颈动脉粥样硬化斑块    
Abstract:Objective To investigate the relationship between the expression of miR-125a-3p and miR-224-3p in serum and carotid atherosclerotic (CAS) plaque in cerebral infarction. Methods A total of 120 patients with cerebral infarction admitted to Beijing Hepingli Hospital from March 2019 to December 2021 were selected and divided into unstable group (75 cases) and stable group (45 cases) according to their CAS plaque stability. Clinical data of the two groups were collected and compared, and the expression of miR-125a-3p and miR-224-3p in serum of the two groups was detected by real-time fluorescent quantitative PCR. The influencing factors of CAS instability in patients with cerebral infarction were analyzed by logistic regression model, and the predictive value of CAS plaque plaque stability in patients with cerebral infarction was further analyzed by receiver operation characteristic (ROC) curve. Results The proportion of smokers, the proportion of diabetic mellitus patients, the level of low-density lipoprotein cholesterol (LDL-C), and the expression of miR-125a-3p in unstable group were higher than those in stable group, and the expression of miR-224-3p was lower than that in stable group, the differences were statistically significant (P<0.05). Multivariate analysis showed that smoking, diabetes mellitus, LDL-C, miR-125a-3p, and miR-224-3p were all influencing factors of CAS plaque instability in patients with cerebral infarction (P<0.05). The area under the ROC curve of the five items combined to predict CAS plaque instability in patients with cerebral infarction was 0.915, and the sensitivity and specificity were 84.00% and 91.11%, respectively. Conclusion Serum miR-125a-3p and miR-224-3p levels in patients with cerebral infarction are associated with CAS plaque instability, which can be predicted by combining smoking, diabetes mellitus, and LDL-C.
Key wordsCerebral infarction    miR-125a-3p    miR-224-3p    Carotid atherosclerosis    Plaque
    
基金资助:北京市卫生健康委员会首都卫生发展科研项目(首发2020-2-2241)。
通讯作者: 李博(1973.6-),女,主任医师;研究方向:脑血管病。   
引用本文:   
李星  刘京锋  李博. 血清miR-125a-3p、miR-224-3p表达与脑梗死患者颈动脉粥样硬化斑块的关系[J]. 中国医药导报, 2023, 20(26): 91-95.
LI Xing LIU Jingfeng LI Bo. Relationship between the expression of miR-125a-3p and miR-224-3p in serum and carotid atherosclerotic plaque in patients with cerebral infar-ction. 中国医药导报, 2023, 20(26): 91-95.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.26.19     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I26/91

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司